Page 831 - ACCCN's Critical Care Nursing

808 I N D E X

patient safety see safety PINI see Prognostic Inflammatory Nutrition musculoskeletal assessment and 111t
patient-at-risk (PAR) score 51, 51t Index obesity and 118
patient-relevant outcomes 40, 40t PIRO staging system see predisposition, pressure area care 112–113
patients’ rights 80–83 infection, response, organ dysfunction rotational therapy 114
consent 80–83 placenta, role of 715–716 of trauma patient 626–627, 628t
to health information collection, use, placenta accreta 722b VTE prophylaxis and 114–115
disclosure 83 placenta praevia 721–722, 722b see also body positioning
to human research 82–83 placental abruption 721 positive end-expiratory pressure (PEEP) 108,
to treatment 81–82 plan-do-study-act (PDSA) 42 392t, 393–394
ethical principles application 83 plaque rupture 216, 216f positron emission tomography (PET), of
nurses’ code of ethics and 80 platelets, administration guidelines, cerebral perfusion 436
Payne-Martin classification system 107 hypovolaemic shock and 545t post dilution 787
PCT see dynamic perfusion computed pleura 326–328, 328f postcentral gyrus 418–419, 422f
tomography pleural effusion 345 posterior cord syndrome 460
PCWP see pulmonary capillary wedge pressure PN see parenteral nutrition postnatal depression (PND) 731
PDA see personal digital assistant PND see postnatal depression postpartum
PDH see pulmonary dynamic hyperinflation pneumonia 357–360, 591 depression 731
PDSA see plan-do-study-act aetiology of 357–359, 358t haemorrhage 721–722, 722b–723b
PDT see percutaneous dilatational technique clinical manifestations of 359–360 in ICU 735–738
PE see pulmonary embolism collaborative practice 360 breast care 736–738
peak airway pressure 392t, 395 medications 360, 361t breast feeding 736–738
PEEP see positive end-expiratory pressure community-acquired 357–358, 359t DVT 736
PELD see paediatric end-stage liver disease diagnosis of 358 lactation initiation 737–738, 737b, 737f
scoring system severity assessment scoring 358 lochia 736
pelvis hospital-acquired 358–359 perineal care 736
fracture classifications of 631f morbidity and mortality 360 uterine involution 735–736
stabilisation of 633–635 pathophysiology of 357 see also pregnancy
with binder application 634f pregnancy and 730 postrenal acute renal failure 484
with external fixateur 634f ventilator-associated 358–359 posttraumatic amnesia (PTA) scale 434–435,
penetrating injuries 643–644 diagnosis of 358–359 435t
perceptions 63 treatment of 358–359 posttraumatic stress disorder (PTSD) 63
percutaneous dilatational technique (PDT), Pneumonia Severity Index (PSI) 357 research vignette for 72b–73b
tracheostomy procedure using 386 pneumoperitoneum 345 posttraumatic stress symptoms (PTSS) 63,
percutaneous transluminal coronary angioplasty pneumothorax 345, 366–367, 636, 637f 64t–65t
(PTCA) 223–224, 223f clinical manifestations of 367 Post-Traumatic Stress Syndrome 10-Questions
nursing management after 223–224 collaborative practice for 367 Inventory (PTSS-10) 61
pericardial rub 191 medications 367, 368t potential multiorgan donor 787
pericardial tamponade, post cardiac pathophysiology of 367 PPE see personal protective equipment
surgery 300–301 tension 367 PPIs see proton pump inhibitors
pericarditis 227 PNS see peripheral nervous system PQRST, for chest pain assessment 217,
pericardium 181 poisoning 596–611 217t
perineal care, in postpartum patient 736 carbon monoxide 603 P-R interval 194–195, 194f
peripartum cardiomyopathy 725–726 Ciguatera 611, 612t practice development 787
peripheral chemoreceptors 329–330 complication prevention 598–599, 599t praecordial thump 660
peripheral nervous system (PNS) 430–431 antidotes 599t precentral gyrus 418–419, 422f
autonomic nervous system 431, 432f diagnostics 597 predilution 787
enteric 431 paracetamol 602 predisposition, infection, response, organ
parasympathetic 431, 432f physical assessment 597 dysfunction (PIRO staging
sympathetic 431, 432f previous history 596–597 system) 551, 551t
motor control 430–431 salicylate 601–602 preeclampsia 716–721, 718b–719b, 718t
sensory control 431 suspected toxin 597 pregnancy
peripheral reflex response 434 time of 597 ALS and 733
permanent pacing 277–279 toxin absorption prevention 597–598 amniotic fluid embolism 722
implantation activities 278 contact poisons 598 antepartum haemorrhage 721–722
parameters 278–279, 278f ingested poisons 597–598 ARDS and 364
personal digital assistant (PDA) 48–49 inhaled poisons 598 asthma and 726–727, 727f
personal hygiene 105–107 toxin elimination from blood 598 BLS and 733
assessment of 105–106 haemodialysis 598 cardiac disease and 727–729
basic 106–107 haemoperfusion 598 case study 739b
skin and tissue assessment 105–106, 106t urine alkalinisation 598 critical illness in 710–711, 711t
skin tears 107, 107t polymorphic ventricular tachycardias 263–264, ectopic 594
personal protective equipment (PPE) 120–121, 264f hepatobiliary changes in 714
787 polyneuropathy, critical illness 58 ICU and 731–735
respiratory pandemics and 362, 362t polysomnography (PSG) 145–146, 787 influenza and 730, 739b–740b
personnel budget 20 pons 421t–422t, 423 mechanical ventilation and 731–732
personnel information 787 population, intervention, comparison, outcome medication administration in 733–735
PET see positron emission tomography (PICO) format 39, 40t mental health disorders and 731
petroleum distillates 604 positioning patient 110–115 obstetric haemorrhage 721–724
PGD see primary graft dysfunction active and passive exercises 111 peripartum cardiomyopathy 725–726
pH 342, 342t–343t for ARDS 364 physiology adaptation of 711–716
phagocytosis 787 assessment 110–111 in cardiovascular system see cardiovascular
physical function, measurement of 60, 60t body position change 112 system
PiCCO see pulse contour cardiac output essential care goals 110 clinical implications of 716, 717t
PICO see population, intervention, comparison, factors to consider when 112t in gastrointestinal system see
outcome format mobilising and 111–115 gastrointestinal system